Zobrazeno 1 - 10
of 200
pro vyhledávání: '"Stéphanie Truant"'
Autor:
Sahir Javed, Stéphane Benoist, Patrick Devos, Stéphanie Truant, Rosine Guimbaud, Astrid Lièvre, David Sefrioui, Romain Cohen, Pascal Artru, Aurélien Dupré, Jean-Baptiste Bachet, Christelle de la Fouchardière, Anne Ploquin, Anthony Turpin
Publikováno v:
World Journal of Surgical Oncology, Vol 20, Iss 1, Pp 1-10 (2022)
Abstract Background BRAF V600E-mutant colorectal cancers (CRCs) are associated with shorter survival than BRAF wild-type tumors. Therapeutic decision-making for colorectal liver metastases (CRLM) harboring this mutation remains difficult due to the s
Externí odkaz:
https://doaj.org/article/396f97762c6d4546b3a537ee0d4435cb
Autor:
Stéphanie Truant, Mehdi El Amrani, Clio Baillet, Anne Ploquin, Katia Lecolle, Olivier Ernst, Mohamed Hebbar, Damien Huglo, François-René Pruvot
Publikováno v:
Annals of Hepatology, Vol 18, Iss 1, Pp 269-273 (2019)
Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy (ALPPS) has emerged as an alternative for patients with bilobar colorectal liver metastasis deemed unresectable due to inadequate future remnant liver (FRL). Nevertheless, hi
Externí odkaz:
https://doaj.org/article/9c1876c0618f4c59acac93e8613ac924
Autor:
Cindy Canivet, Sophie Gourgou-Bourgade, Bertrand Napoléon, Laurent Palazzo, Nicolas Flori, Pierre Guibert, Guillaume Piessen, Dominique Farges-Bancel, Jean-François Seitz, Eric Assenat, Véronique Vendrely, Stéphanie Truant, Geoffroy Vanbiervliet, Philippe Berthelémy, Stéphane Garcia, Anne Gomez-Brouchet, Louis Buscail, Barbara Bournet, The BACAP Consortium
Publikováno v:
BMC Cancer, Vol 18, Iss 1, Pp 1-8 (2018)
Abstract Background The prognosis for pancreatic cancer remains poor despite diagnostic advances and treatments with new chemotherapeutic regimens. The five year survival rate remains below 3%. Consequently, there is an urgent need for new treatments
Externí odkaz:
https://doaj.org/article/55b2d79dadfb4ff492665ac20efed17e
Autor:
Charlotte Maulat, Cindy Canivet, Célia Touraine, Sophie Gourgou, Bertrand Napoleon, Laurent Palazzo, Nicolas Flori, Guillaume Piessen, Pierre Guibert, Stéphanie Truant, Eric Assenat, Louis Buscail, Barbara Bournet, Fabrice Muscari, the BACAP Consortium
Publikováno v:
Cancers, Vol 12, Iss 4, p 783 (2020)
Surgery remains the only curative treatment for pancreatic ductal adenocarcinoma (PDAC). Therefore, a predictive score for resectability on diagnosis is needed. A total of 814 patients were included between 2014 and 2017 from 15 centers included in t
Externí odkaz:
https://doaj.org/article/91745fd000e94761a18a0fa3f4182b76
Autor:
Pauline Gras, Stéphanie Truant, Valérie Boige, Laure Ladrat, Philippe Rougier, François-René Pruvot, Mohamed Hebbar
Publikováno v:
Case Reports in Oncology, Vol 5, Iss 1, Pp 169-172 (2012)
The only currently validated treatment for advanced hepatocellular carcinoma (HCC) is sorafenib. However, sorafenib has been mainly studied in patients with HCC developed in cirrhotic liver. Chemotherapy might be more suitable for patients with HCC i
Externí odkaz:
https://doaj.org/article/084c1c66061b424ca3bbfb1194739ff5
Autor:
Charlotte Maulat, Stéphanie Truant, Christian Hobeika, Louise Barbier, Astrid Herrero, Alexandre Doussot, Johan Gagnière, Édouard Girard, Hadrien Tranchart, Jean-Marc Regimbeau, David Fuks, François Cauchy, Mathieu Prodeau, Antoine Notte, Cyprien Toubert, Ephrem Salamé, Mehdi El Amrani, Sandrine Andrieu, Fabrice Muscari, Jason Shourick, Bertrand Suc
Publikováno v:
Hepatobiliary Surgery and Nutrition. 12:192-204
Autor:
David Tulasne, Véronique Fafeur, Yvan De Launoit, Gérard Zalcman, Marie-Christine Copin, Françoise Galateau-Sallé, Jean-Christophe Sabourin, Pierre Michel, Stéphanie Truant, Ludivine Beaussire, Nathalie Rousseau, Laurence Wicquart, Gautier Goormachtigh, Audrey Vinchent, Mélanie Bénozène, Nasrin Sarafan-Vasseur, Shéhérazade Sebda, Céline Villenet, Charline Frandemiche, Frédéric Leprêtre, Martin Figeac, Leslie Duplaquet
Supplementary Figure S7: Fibroblast transformation with each of the 8 somatic-mutation-harboring RTKs
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::596956bcd95fc0f81e8fa4ef3829b363
https://doi.org/10.1158/1535-7163.22510255.v1
https://doi.org/10.1158/1535-7163.22510255.v1
Autor:
David Tulasne, Véronique Fafeur, Yvan De Launoit, Gérard Zalcman, Marie-Christine Copin, Françoise Galateau-Sallé, Jean-Christophe Sabourin, Pierre Michel, Stéphanie Truant, Ludivine Beaussire, Nathalie Rousseau, Laurence Wicquart, Gautier Goormachtigh, Audrey Vinchent, Mélanie Bénozène, Nasrin Sarafan-Vasseur, Shéhérazade Sebda, Céline Villenet, Charline Frandemiche, Frédéric Leprêtre, Martin Figeac, Leslie Duplaquet
Supplementary Table S1: Detailed annotation of the somatic mutations in the 58 RTKs, KRAS, PI3KCA, and TP53
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4e38c3391942c179d9efd07e3223066a
https://doi.org/10.1158/1535-7163.22510252
https://doi.org/10.1158/1535-7163.22510252
Autor:
David Tulasne, Véronique Fafeur, Yvan De Launoit, Gérard Zalcman, Marie-Christine Copin, Françoise Galateau-Sallé, Jean-Christophe Sabourin, Pierre Michel, Stéphanie Truant, Ludivine Beaussire, Nathalie Rousseau, Laurence Wicquart, Gautier Goormachtigh, Audrey Vinchent, Mélanie Bénozène, Nasrin Sarafan-Vasseur, Shéhérazade Sebda, Céline Villenet, Charline Frandemiche, Frédéric Leprêtre, Martin Figeac, Leslie Duplaquet
Besides the detection of somatic receptor tyrosine kinases (RTK) mutations in tumor samples, the current challenge is to interpret their biological relevance to give patients effective targeted treatment. By high-throughput sequencing of the 58 RTK e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ab912ca760f193d310ecf0edca4a770
https://doi.org/10.1158/1535-7163.c.6539557
https://doi.org/10.1158/1535-7163.c.6539557
Autor:
Guillemette Huet, Renata Polakowska, Christian Gespach, Isabelle Van Seuningen, Pierre Formstecher, Lee M. Ellis, Fan Fan, Mohamed Hebbar, François-René Pruvot, Stéphanie Truant, Patrick Dumont, Emmanuelle Leteurtre, Guillaume Millet, Georges Grard, Carole Langlois, Nicolas Skrypek, Laurence Stechly, Didier Monté, Jérôme Vandomme, Anne-Frédérique Dessein, Matthieu Corvaisier, Wassila Igoudjil, Yasmine Touil
PDF file - 55K, Table S1. Expression of cell surface stem cell markers in parental HT29 cells, its 5FUresistant 5F7 and 5F31 clonal derivatives, 5FU- and oxaliplatin-resistant HT29FU and HT29OXA subpopulations.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::11f3fa04a169179804e236067182bca2
https://doi.org/10.1158/1078-0432.22447895.v1
https://doi.org/10.1158/1078-0432.22447895.v1